Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
about
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trialInterference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain responseClinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgiaEffects of Whole-Body Vibration Therapy in Patients with Fibromyalgia: A Systematic Literature ReviewThe Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic AspectsEconomic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies.Chronic pain and health care spending: an analysis of longitudinal data from the Medical Expenditure Panel Survey.Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilization.Toward characterization and definition of fibromyalgia severity.Exercise and global well-being in community-dwelling adults with fibromyalgia: a systematic review with meta-analysisThe need for knowledge translation in chronic pain.Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis"Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments".Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care.Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness SurveySocietal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey.Efficacy of transcranial direct current stimulation and repetitive transcranial magnetic stimulation for treating fibromyalgia syndrome: a systematic review.An update on pharmacotherapy for the treatment of fibromyalgia.Fibromyalgia: management strategies for primary care providers.Duloxetine for the treatment of fibromyalgia.Massage therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials.A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, MinnesotaThe comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical records.Efficient practices associated with diagnosis, treatment and management of fibromyalgia among primary care physicians.Fibromyalgia-related costs and loss of productivity: a substantial societal burden.Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgiaA pilot study of health and wellness coaching for fibromyalgia.Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States.Correlates of perceived pain-related restrictions among women with fibromyalgiaHealth-resource use and costs associated with fibromyalgia in France, Germany, and the United States.Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trialReliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgiaReal-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.Pirlindole in the treatment of depression and fibromyalgia syndrome.Including a range of outcome targets offers a broader view of fibromyalgia treatment outcome: results from a retrospective review of multidisciplinary treatment.
P2860
Q24607936-F95B5AF1-0B8F-4FE7-9263-FD47370522A8Q24610551-2001D958-CB27-4CBA-9449-FDB1252671C5Q26764876-2888EF53-8B8C-46D7-A355-8E7F0AAD9DB7Q26782459-440DF204-A918-4A12-B6FB-8ACA84FF8375Q26801572-2F967692-72B7-4A1C-8B76-76184E1CBA33Q30244295-A549DCA6-81D2-452B-8F8F-C2DBCD897BBFQ30871976-FEF1F366-EED2-4E00-9777-4A170BE65261Q30912149-30C5D224-281B-4D65-927B-85806EB6CDD2Q33551013-F2C632D5-7AAA-4CB8-8525-BF2C551CAD0FQ33560462-B73B1CB7-8D50-4CE6-B184-D89B70ABA0ECQ33562393-E86C6218-A0C9-4AE3-8A21-BA389F6C8169Q33618549-9AEC58FC-A1FF-47CF-9CE0-A8FFA0545A0AQ33743545-82DF7F52-D383-4402-A54F-3C2D9CAF3904Q33766468-758D2503-0453-4290-9A29-76FCB242DFB5Q33884111-FC791760-940D-44FC-9A90-ECB1FFC89280Q34160641-D0ABAA15-7592-4E20-B744-6EA0F07715BEQ34196818-AA8B11C2-31D2-4F22-8BE9-F1198BECA4DAQ34282636-D3B9D69A-4203-46A2-A31C-84872A8D4F24Q34477510-164455EC-C79B-490F-829D-8529A479F4C2Q34511064-93223222-57F2-4DD0-A2B7-53759F9B0D30Q34663934-0EEAECD6-9D3E-4CE3-A383-8D4AD3CCAC3BQ35107036-A7C23217-7A78-492D-8615-18D993793EB9Q35179923-6076B331-1AB3-419C-9969-958A4CA0DD91Q35231146-6BF2E24E-73CC-47A6-931B-5A392A163847Q35633313-0D9853AB-F543-48BB-B752-288CC82A1505Q35743484-659FC295-6DC5-402B-9859-009AC47129DDQ35816681-275DAB0A-94CD-4C76-8EAF-7C4560E04D37Q35991527-38E6A501-DA7F-4573-998C-ED5E0359D5F1Q36059500-4D5327AA-CE69-472A-A085-C49B767F6EDCQ36184906-4E9869EF-4048-4BDC-8708-21FDCCBE6D2DQ36246938-9AB9EE94-5212-414A-9B61-66B47AA212FEQ36515967-6DA49A11-5BF1-42CD-9A60-8C3AADB177B1Q36797580-CDFCF2D9-A987-42E8-AE3A-E87A12AB7DB9Q36834489-1ED765FB-AE84-4682-A336-0B1819C428DDQ37122687-5FF1677C-9E0C-44CB-A14D-3F153DDFC6B3Q37478527-F7F76961-47CF-4BB4-B1B2-C8EB1D6942A1Q37844532-D2EF6BFB-F4EA-4BFF-AEBF-B3DDCA6502D7Q37880281-D3A7901A-5485-4DF3-A3FB-5A0C2B5A0AE9Q37923925-AE6C87E5-E153-444F-AC9A-D65DF7CCA797Q38123453-256FDA7F-9488-4D9B-8BEF-61631910FDB6
P2860
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@en
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@nl
type
label
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@en
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@nl
prefLabel
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@en
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@nl
P2093
P1476
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
@en
P2093
Anna Kaltenboeck
David Mallett
Howard G Birnbaum
Leigh Ann White
Rebecca L Robinson
P356
10.1097/JOM.0B013E31815CFF4B
P407
P50
P577
2008-01-01T00:00:00Z